abstract |
The present invention relates to novel human coagulation factor VIIa variants having coagulation activity, as well as nucleic acid constructs encoding such variants, vectors and host cells comprising and expressing nucleic acids, pharmaceutical compositions, methods of use and treatment.n n n Coagulation factor VII variant. |